Aclipse Therapeutics: Latest News, Top Stories & Analysis

Aclipse Targets Kidney Disease With Cypress Acquisition Option

October 2, 2026September 30, 2026 - by Timothy Alexander

KING OF PRUSSIA, PA — Aclipse Therapeutics secured an option to acquire Cypress BioPharma, a deal that would expand its lead M107 drug candidate into childhood nephrotic syndrome and give …

Regional

Aclipse, Mayo Clinic Team Up on Trial for First Drug Aimed at Halting Gastroparesis

November 29, 2025November 28, 2025 - by Timothy Alexander

KING OF PRUSSIA, PA — Aclipse Therapeutics has entered a clinical collaboration with Mayo Clinic to advance a Phase 2 study of M107, a novel small-molecule drug positioned as the …